Mitochondrial Damage and Apoptosis Induced by Adenosine Deaminase Inhibition and Deoxyadenosine in Human

Mercedes Garcia-Gil1, Maria Grazia Tozzi2, Francesco Balestri2

  • 1Dipartimento di Biologia, Unità Fisiologia Generale, Via S. Zeno 31, Pisa, Italy.

Insights

The combined treatment of deoxycoformycin and deoxyadenosine induces apoptotic cell death in neuroblastoma cells. This purine metabolism perturbation suggests novel therapeutic strategies for nervous system tumors.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Neuroblastoma is a pediatric cancer with limited treatment options.
  • Adenosine deaminase (ADA) plays a role in purine metabolism.
  • Perturbing purine metabolism can induce cancer cell death.

Purpose of the Study:

  • To investigate the effects of deoxycoformycin and deoxyadenosine on human neuroblastoma cell lines.
  • To elucidate the mechanisms of cell death induced by this combination treatment.
  • To compare the response of neuroblastoma cells with astrocytoma cells to this treatment.

Main Methods:

  • Treatment of SH-SY5Y and LAN5 neuroblastoma cell lines with deoxycoformycin and deoxyadenosine.
  • Assessment of mitochondrial reactive oxygen species (ROS) and mitochondrial mass.
  • Analysis of nuclear fragmentation and caspase activation (caspase-8, -9, and -3).

Main Results:

  • The combination treatment rapidly decreased mitochondrial ROS and increased mitochondrial mass in SH-SY5Y cells.
  • Later, nuclear fragmentation and activation of caspases -8, -9, and -3 were observed.
  • Neuroblastoma cell lines exhibited apoptotic cell death, similar to astrocytoma cells, but with distinct mechanistic differences.

Conclusions:

  • Neuroblastoma cells are sensitive to purine metabolism perturbation induced by deoxycoformycin and deoxyadenosine.
  • The observed cell death mechanisms involve mitochondrial dysfunction and caspase activation.
  • This study suggests potential new therapeutic approaches for nervous system tumors by targeting purine metabolism.

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.5K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
18.8K